Studienserver - Medizinische Hochschule Hannover

Studies: CLBH589G2101

ID Trial

EudraCT number

Clinicaltrials.gov identifier

Description

A phase Ib, dose-finding study of oral panobinostat (LBH589) in combination with idarubicin and cytarabine induction and high-dose cytarabine-based consolidation therapy in adult patients less than or equal to 65 years old with acute myeloid leukemie (AML)

Status